Birdwatch Note
2024-12-31 03:18:21 UTC - NOT_MISLEADING
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination https://link.springer.com/article/10.1007/s00392-022-02129-5#Sec3 mRNA "vaccine" biodistribution, persistence, and adjuvant toxicity library https://zenodo.org/records/14559625
Written by 684E65261B63E8DAB10C28FFE043C033F4BC7F3B3BFD9398678F764A4F9166AD
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1873788747311157499
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1873931673697738979
- noteId - 1873931673697738979
- participantId -
- noteAuthorParticipantId - 684E65261B63E8DAB10C28FFE043C033F4BC7F3B3BFD9398678F764A4F9166AD Participant Details
- createdAtMillis - 1735615101633
- tweetId - 1873788747311157499
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination https://link.springer.com/article/10.1007/s00392-022-02129-5#Sec3 mRNA "vaccine" biodistribution, persistence, and adjuvant toxicity library https://zenodo.org/records/14559625
Note Ratings
rated at | rated by | |
2025-01-02 03:13:22 -0600 | Rating Details | |
2025-01-01 04:01:50 -0600 | Rating Details | |
2024-12-31 09:48:19 -0600 | Rating Details | |
2024-12-31 03:23:08 -0600 | Rating Details | |
2024-12-31 01:05:16 -0600 | Rating Details | |
2024-12-30 21:53:39 -0600 | Rating Details | |
2024-12-30 21:42:47 -0600 | Rating Details | |
2025-01-01 01:06:57 -0600 | Rating Details | |
2024-12-31 14:05:39 -0600 | Rating Details | |
2024-12-31 13:22:17 -0600 | Rating Details | |
2024-12-31 10:28:39 -0600 | Rating Details | |
2024-12-30 23:39:31 -0600 | Rating Details | |
2024-12-30 21:40:14 -0600 | Rating Details | |
2024-12-31 00:13:25 -0600 | Rating Details | |
2024-12-30 21:34:58 -0600 | Rating Details | |
2024-12-30 21:33:34 -0600 | Rating Details | |
2024-12-31 14:36:20 -0600 | Rating Details | |
2024-12-31 00:37:44 -0600 | Rating Details |